Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01038128 · ClinicalTrials.gov registry record · NA
An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder
A NA study, sponsored by Mclean Hospital.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01038128 is a NA study that has completed, run by Mclean Hospital. The registered enrollment target is 5 participants.
The verdict
NCT01038128, a NA study, has completed, sponsored by Mclean Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The primary objective of this 13-week clinical trial is to test the hypothesis that treatment with Memantine will significantly improve the symptoms of those suffering from either bulimia nervosa, purging type or suffering from body dysmorphic disorder.
Interventions
- DRUG Memantine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2009-12 |
| Est. Completion | 2011-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01038128
The ClinicalTrials.gov registry entry for NCT01038128 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mclean Hospital, which has 140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Memantine is the first listed.
NCT01038128 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01038128 about?
NCT01038128 is a clinical study titled "An Open Label Trial of Memantine in the Treatment of Bulimia Nervosa and Body Dysmorphic Disorder". The primary objective of this 13-week clinical trial is to test the hypothesis that treatment with Memantine will significantly improve the symptoms of those suffering from either bulimia nervosa, purging type or suffering from body dysmorphic disorder.
What is the current status of trial NCT01038128?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2009-12. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01038128?
The interventions under investigation include: Memantine (DRUG).
Who is sponsoring clinical trial NCT01038128?
This trial is sponsored by Mclean Hospital, which has 140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.